scholarly journals The Effects of Triethylene Melamine and Related Compounds on the Leukocytes of Mouse Leukemia

Blood ◽  
1951 ◽  
Vol 6 (6) ◽  
pp. 504-512 ◽  
Author(s):  
JOSEPH H. BURCHENAL ◽  
LORRAINE F. WEBBER ◽  
JUNE L. BIEDLER ◽  
G. MARIE MEIGS ◽  
GODFREY D. STOBBE

Abstract 1. In the usual therapeutic dosage in mice with the Ak4 strain of leukemia, TEM caused a prolongation of survival time, held the total leukocyte count down at severely leukopenic levels, delayed the appearance of immature lymphocytes in the peripheral blood, and caused a marked delay in the appearance of leukemic infiltrations of the liver, spleen, bone marrow and kidney. 2. A single massive dose of TEM, administered on the seventh day of the disease when the total leukocyte count was high, caused a rapid fall in the count and depressed the number of prolymphocytes in the peripheral blood. 3. Single massive doses of such structurally related compounds as hexamethylene diethylenurea, 2,4-diethylenimino-6-amino-s-triazine, and to a lesser degree, 2-ethylenimino-4,6-dimethoxy-s-triazine caused a similar fall in the total leukocyte count when administered on the seventh day of the disease.

Blood ◽  
1950 ◽  
Vol 5 (2) ◽  
pp. 167-176 ◽  
Author(s):  
J. H. BURCHENAL ◽  
J. L. BIEDLER ◽  
J. NUTTING ◽  
G. D. STOBBE

Abstract 4-Amino-N10-methyl-pteroylglutamic acid in the usual treatment dosage caused a slight leukopenia, but no change in the differential count of normal mice. However, in animals with the Ak 4 strain of transplanted leukemia, such dosage caused prolongation of survival time, held the total leukocyte count at approximately normal levels, decreased the percentage of abnormal cells, and caused a marked delay in the appearance of leukemic infiltrations in liver, spleen, lymph nodes, kidney and bone marrow. Less than twenty hours after administration, a single massive dose of this drug caused a fall in the total leukocyte count of mice with advanced Ak 4 leukemia.


2014 ◽  
Vol 7 (1) ◽  
pp. 33-40 ◽  
Author(s):  
Sunita Pande ◽  
Prabhu Narain Saxena ◽  
Brijender Bhushan ◽  
Nishi Saxena

Abstract Pyrethroids, commercially available pesticides, are greatly in use these days, and thus they carry considerable chances of contaminating various ecosystems. Haematotoxicity of cypermethrin, a broadly used type II pyrethroid, has been assessed in the present study. Selected parameters included determination of total RBC count, haemoglobin concentration (Hb conc.), packed cell volume (PCV), mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), mean corpuscular haemoglobin concentration (MCHC), erythrocyte sedimentation rate (ESR), total leukocyte count (TLC), differential leukocyte count (DLC), along with qualitative analysis of blood and bone marrow. Of these parameters, those showing significant decline following cypermethrin intoxication included total RBC count, Hb conc., PCV, MCV, MCH, whereas non-significant decrease was observed in the case of MCHC. ESR, TLC and DLC, on the other hand, increased significantly following cypermethrin intoxication. Qualitative changes included altered red cell morphology such as microcystosis, appearance of stomatocytes, poikilocytosis, giant platelet formation, etc. in peripheral blood and increased erythroid precursors in bone marrow of treated rats. These parameters were however normalised following twenty-two days of recovery phase


Blood ◽  
1951 ◽  
Vol 6 (1) ◽  
pp. 3-15 ◽  
Author(s):  
J. G. PALMER ◽  
ILEEN KEMP ◽  
G. E. CARTWRIGHT ◽  
M. M. WINTROBE

Abstract 1. Following splenectomy in the albino rat, the total leukocyte count increased approximately 100 per cent in seven days, and remained significantly elevated for seventy to ninety days, after which time time leukocytes returned to normal levels. This increase in circulating leukocytes was due to an increase in both neutrophils and mononuclear cells. Partial omentectomy and unilateral nephrectomy produced increases of less magnitude and much shorter duration than those which followed splenectomy. 2. Removal of as much as 75 per cent of the spleen resulted in a leukocyte increase resembling in magnitude and duration that of control operations. 3. When small portions (less than 10 per cent) of the spleen were transplanted to other sites, the leukocyte response also resembled that which followed the control operations. 4. When splenectomy was performed in one partner of parabiotic rats, no rise occurred in the leukocyte count of either animal. When the spleen of the second partner was then removed, a rise in the leukocyte count of both animals occurred. 5. When rats were made leukopenic by pteroylglutamic acid deficiency, no rise in the leukocytes in the peripheral blood occurred following splenectomy. 6. It is concluded that in the rat the spleen exerts an influence on the level of circulating leukocytes, and that the results of these experiments support but do not conclusively prove the hypothesis that this organ exerts this influence by controlling the rate of production and/or liberation of leukocytes in the bone marrow. These studies do not exclude the possibility that under certain circumstances the spleen may destroy white cells.


QJM ◽  
2021 ◽  
Vol 114 (Supplement_1) ◽  
Author(s):  
Samar El Sharkawy ◽  
Riham Hazem Raafat ◽  
Reem Osama Mohamed Ahmed Qassem

Abstract Background The Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines define COPD as a disease state characterized by airflow limitation that is not fully reversible, is usually progressive, and is associated with an abnormal inflammatory response of the lungs to inhaled noxious particles or gases. Objective To identify outcomes of patients with eosinophilic COPD exacerbations requiring hospital admission. Patients and Methods This study is a prospective cohort study that was conducted on two groups of total 60 patients recruited from Ain Shams University hospitals between October 2019 and July 2020. Group 1: Eosinophilic COPD exacerbation if the peripheral blood eosinophil on admission is ≥ 200 cells/µL and/or ≥2% of the total leukocyte count Group 2: Non-eosinophilic COPD exacerbation if the peripheral blood eosinophil on admission is < 200 cells/µL and/or < 2% of the total leukocyte count. Results There was significant high diagnostic performance in predicting readmission at 6-month among eosinophilic group. Eosinophils count, percent (%) and NLR cutoff points had high characteristics (highest in NLR ≥3.1 at discharge) in predicting readmission at 6-month among eosinophilic group. Diagnostic performance of Eosinophils count, percent (%) and NLR were assessed. Eosinophils count, percent (%) and NLR had significant high diagnostic performance in predicting readmission at 6-month among eosinophilic group. Eosinophils count, % and NLR cutoff points had high characteristics (highest in NLR ≥2.1 at discharge) in predicting readmission at 6month among non-eosinophilic group. Conclusion Eosinophils can be used as a prognostic marker in non-infective COPD exacerbations. Validity of eosinophil count and percent as a prognostic parameter in COPD exacerbation can be increased by combining with other parameters for example NLR.


Medicina ◽  
2007 ◽  
Vol 43 (1) ◽  
pp. 60 ◽  
Author(s):  
Vilma Jurkštienė ◽  
Anatolijus Kondrotas ◽  
Egidijus Kėvelaitis

The aim of the study was to investigate the immunostimulatory properties of bigroot geranium. Material and methods. Possible nonspecific characteristics of bigroot geranium were evaluated by the total leukocyte count in the peripheral blood, and qualitative changes of blood were assessed using Shilling’s formula by evaluating changes in lymphocyte counts. In addition, we also studied changes in the counts of Tcell precursors in the thymus and B lymphocytes in the spleen. Ethanol extract of the leaves of bigroot geranium was produced at the Department of Food Technology, Kaunas University of Technology. Studies were performed on mice Bl 57 (n=21). The control group (n=7) received distilled water at a dose of 1 mL/day. The second and third groups received 1% and 10% extract of bigroot geranium, respectively, as a food supplement. Changes in cell counts were investigated after 4 weeks following the initiation of the trial. Results. After a 4-week administration of 1% extract of bigroot geranium (1 mL/day) (mice group, n=7), leukocyte count in the peripheral blood increased to 6.1×109 cells/L, and lymphocyte count – to 70%, but changes were not statistically significant. The other case group of mice (n=7) received 10% extract of bigroot geranium for 4 weeks at a dose of 1 mL/day. In this group, leukocyte count in the peripheral blood increased statistically significantly from 4.4×109 cells/L to 7.2×109 cells/L (p<0.01), and lymphocyte percentage – from 52% to 80% (p<0.001), as compared to control. Thymocyte (T lymphocytes) counts in thymus and splenocyte (B lymphocytes) counts in the spleen showed a tendency to increase after the administration of 1% and 10% extracts. After a 4-week administration of 1% extract of bigroot geranium, thymocyte and splenocyte counts increased from 0.342×106 cells to 0.372×106 cells per mg of tissue and from 0.395×106 cells to 0.405×106 cells per mg of tissue, respectively, as compared to control group (p>0.1). After the administration of 10% extract of bigroot geranium, thymocyte count increased to 0.488×106 cells per mg of tissue (p<0.01), and splenocyte count – to 0.504×106 cells per mg of tissue (p<0.01). Conclusion. The extracts of the leaves of bigroot geranium increased leukocyte count and lymphocyte percentage in the peripheral blood, and after a 4-week administration of 10% extract of bigroot geranium, a statistically significant increase in the counts of T lymphocytes (in the thymus) and B lymphocytes (in the spleen) was observed. The immunostimulatory effect depends on the dose of the extract.


2016 ◽  
Vol 2016 ◽  
pp. 1-6 ◽  
Author(s):  
Jun Li ◽  
Hong Chen ◽  
Yan-Bo Lv ◽  
Qiang Wang ◽  
Zheng-Jun Xie ◽  
...  

Coinfusion of hematopoietic and mesenchymal stem cells is more effective than hematopoietic stem cell transplantation alone. It is necessary to explore a safe and routine mixed stem cell intraperitoneal transplantation method. Multiplacentas pooled cells were intraperitoneally injected into a radiation- and immunity-induced mouse aplastic anemia model with single time. Then, mouse survival time, peripheral blood hemoglobin count, bone marrow architecture, and donor cell engraftment were assessed. The recipient mouse exhibited donor cell engraftment in both bone marrow and peripheral blood. Survival time and peripheral blood hemoglobin count increased in placenta pooled cells treated mice, compared with model-only controls (P=0.048andP=0.000, resp.). However, placentas pooled cells failed to cause a significant decrease in bone marrow pimelosis area (P=0.357). Intraperitoneally transplanted multiplacentas pooled cells can survive and engraft into a host body through blood circulation, which can increase the life span of an aplastic anemia model mice, and delay but not abrogate the development of aplastic anemia. Furthermore, they appear to play a role in increasing peripheral blood hemoglobin level response for increasing the life span of aplastic anemia model mice.


PEDIATRICS ◽  
1956 ◽  
Vol 18 (4) ◽  
pp. 643-660
Author(s):  
Joseph H. Burchenal ◽  
M. Lois Murphy ◽  
Charlotte T. C. Tan

IN TREATMENT of acute leukemia in children, as in treatment of any form of cancer, early diagnosis is of great importance. Although in contrast to many other tumors in children, leukemia is never curable even when detected at the early stages, the sooner treatment can be initiated, the more chance there is of having sufficient time to achieve a beneficial effect. The most important single factor in making the diagnosis of leukemia is a high degree of suspicion. Patients with pains in the bones and joints, with any hemorrhagic tendency, with increased susceptibility to infection or with an unexplained anemia or fever should have an immediate determination of total and differential leukocyte count, hemoglobin, and platelets. If any abnormality is found or if the symptoms persist, a bone marrow aspiration is essential. If these procedures are utilized, it is the rare case in which the diagnosis cannot be made with relative ease. In most cases of acute leukemia, there is almost complete replacement of the normal elements in the marrow by leukemic cells. Depression or absence of erythropoietic activity in the marrow and possibly decreased life span of the circulating erythrocytes leads to severe anemia with the accompanying symptoms of pallor, easy fatigability, and dyspnea on exertion. The decreased megakaryocytic activity in the bone marrow and the decrease of platelets in the circulating blood lead to petechiae, ecchymoses, and other hemorrhagic manifestations. In the peripheral blood the total leukocyte count may be high, normal, or low but, as most of the cells are abnormal in type, the patient is less able to combat infection.


Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 3761-3761
Author(s):  
Sushma Nakka ◽  
Yelena Patsiornik ◽  
Svetlana Reznik ◽  
Gloria Fernandez ◽  
Archana Maini ◽  
...  

Abstract A 26-year old woman with diagnosis Anorexia Nervosa, restricting type presented to the ED with refusal to eat, weakness and amenorrhea. She weighted 29.2 kg, which at a height of 5 ft made her BMI 12.6 kg/m2. Laboratory data showed a hemoglobin of 9.3/dl, hematocrit of 28.4%, leukocyte count of 8.9 K/ul, platelets count 131 K/ul. Ferritin was 168.4 ng/ml, serum iron 80 mcg/dL, transferin saturation 35.7%. Initial chemistries revealed albumin of 3.5 g/dl, prealbumin 12.4 mg/dl. Following hydration, the hemoglobin level fell to 6.9 g/dl, hematocrit to 22.0%. Remarkably, patient also experienced transient leukopenia (3.0 K/ul) and thrombocytopenia (92 K/ul). Peripheral blood smear revealed anisocytosis, polychromasia, hypochromia and RBC fragments. The histological examination of bone marrow biopsy and aspirate showed almost complete depletion of hematopoietic tissue with rare erythroid, myeloid cells and occasional megakaryocyte. Fat tissue was completely melted presenting Gelatinous Degeneration, no stainable iron was seen. The flow cytomery did not show abnormal myeloid maturation, increased blast population or lymphoproliferative disorder. Smear prepared from the flow sample contained maturing myeloid and erythroid cells. Reticulocytes were preserved and accounted for 0.7%. The patient was treated with blood transfusions and nutritional support. After 2 months, all biochemical imbalances and hematological parameters normalized. This is reflected in a hemoglobin level of 10.5g/dL, hematocrit of 31.3%, leukocyte count of 5.7 K/ul and platelet count of 371 K/ul. On the day of discharge to Anorexia Nervosa Clinic patient weighted 32.0 kg. Although abnormalities in the peripheral blood are common in anorexia nervosa, in the rare cases anorexia may be associated with hypo- and aplasia, variable hypocellularity and complete Gelatinous Degeneration Bone Marrow. GDBM is an extreme condition significantly related to bone marrow necrosis and characterized by reduction of fat spaces and accumulation of material rich in acid mucopolysacharides, what we observed in our patient. The bone marrow fat depletion could adversely affect the local environment and interfere with normal hematopoiesis by way of an alteration in the release cytokines or growth factors. We have hypothesized that Gelatinous Degeneration Bone Marrow related only to the amount of weight loss; not to other factors such as duration of caloric deprivation, age or clinical type of anorexia. In most anorexia cases in the literature, alterations of bone marrow were reflected in the peripheral blood as mild or no cytopenia. However, we found that peripheral blood findings do not correlate with bone marrow changes, and are not good predictors of bone marrow involvement in anorexia nervosa. As a result, bone marrow morphology should be reviewed to assess severity of hematologic abnormalities in this instance. Our findings confirmed that even severe aplastic bone marrow alterations as gelatinous degeneration, as well as abnormalities in the peripheral blood is a reversible process conditioned to weight recovery after establishment of adequate nutrition. Importantly, clinical significance of the laboratory abnormalities and medical findings in anorexia nervosa patients has not been firmly established. We do not have risk-stratification for treatment, what is crucial for reversing a common, but seems under recognized problem in our ‘obsessed with weight loss’ culture.


Blood ◽  
2013 ◽  
Vol 122 (21) ◽  
pp. 5551-5551
Author(s):  
Shatha Farhan ◽  
Catherine Carroll ◽  
Danielle Pelland ◽  
Jose Carlos Velasco ◽  
Susan Wautelet ◽  
...  

Abstract Background Myelodysplastic syndromes (MDS) are a heterogeneous group of malignancies characterized by dysplasia, cytopenia, ineffective hematopoiesis and by an increased risk of transformation to acute myeloid leukemia (AML). Recurrent aberrant karyotypes cannot entirely account for the genetic defects that are at the basis of the pathogenesis of MDS, as they are detected only in approximately 50% of patients. Allogeneic hematopoietic cell transplantation (HCT) likely prolongs survival in patients with AML and MDS. In this report, we evaluated the impact of presence of dyspoesis in paients with AML with or without cytogenetic (CG) abnormality on outcome in our center. Methods We retrospectively reviewed all patients who were diagnosed with AML (non promyelocytic) in our center between 2002 and 2012. Primary objective was to study the impact of MDS with or without CG abnormalities on outcome of patients with AML. Demographics and disease-related variables were collected. OS was defined as the time from diagnosis to the time of death or last contact. Results Between 2002 and 2012, 123 patients with high or intermediate risk AML patients were treated at our center. Median age at diagnosis was 60 (range 19-89). Median OS for all patients was 368 days. Of 123 patients, 51 had MDS while 73 did not. CG abnormalities were present in 35 (68%) of patients with dyspoetic changes. Median age of AML patients with MDS was 59 while median age of AML without MDS patients was 55. Median number of blasts in bone marrow and peripheral blood in AML patients with MDS was 38% and 6% respectively. While median number of blasts in bone marrow and peripheral blood in AML patients without MDS was 67% and 39% respectively. Of 51 AML patients with MDS, 14 received HCT with median age of 56. Half of these received myeloablative regimen while the other half received reduced toxicity regimen. The median survival time for AML patients without MDS was 401 days while the median survival time for AML patients with MDS was 278 days (p = 0.0201), Fig1. For AML with MDS who received HCT, the median survival time was 586 days while it was 164.5 days for AML patient with MDS who did not receive HCT (p = 0.0013), Fig2. Conclusion In this small cohort from a single center, the results suggest that AML patients with dyspoetic changes do have a worse prognosis despite having lower percentage of blasts in bone marrow or peripheral blood. This can be explained by what Walter et al reprted, using next-generation sequencing, that the proportion of neoplastic marrow cells is indistinguishable in MDS and secondary-AML even with myeloblast count of zero. HCT can be performed in those patients including older patients with promising results. Disclosures: No relevant conflicts of interest to declare.


Blood ◽  
1951 ◽  
Vol 6 (4) ◽  
pp. 337-343 ◽  
Author(s):  
J. H. BURCHENAL ◽  
L. F. WEBBER ◽  
G. M. MEIGS ◽  
J. L. BIEDLER

Abstract 1. Further studies contrasting the effect of varying doses of 4-amino-N10-methyl-PGA on a resistant variant (Ak4R) of transplanted mouse leukemia Ak4 have been reported. 2. The usual therapeutic dosage of 4-amino-N10-methyl-PGA prevented the increase in total leukocytes, delayed the visceral infiltration, and increased survival time in the Ak4 strain but was without effect in strain Ak4R. 3. In the Ak4 leukemic mice with high leukocyte counts a marked drop within twenty-four hours could be demonstrated after a single dose of 3 mg./Kg. of this drug. With the Ak4R strain there was sufficient resistance so that a dose of at least 25 mg. Kg. was needed to show the marked leukopenia in twenty-four hours. 4. The Ak4R strain was as sensitive as the Ak4 to the leukotoxic effects of 2,6-diaminopurine. This drug also was effective in prolonging the survival time of mice with Ak4R leukemia.


Sign in / Sign up

Export Citation Format

Share Document